Hello. Just on the peptide business. So, we said that we will turn profitable. Are we expecting to turn PAT profitable or EBITDA profitable by Q4?
And do we see a lot of program coming in in this business, that is why we are expecting this PAT profitable from Q4 or this is mostly on...How do we expect this growth to happen?